The changing therapeutic landscape for hepatitis CDORE, Gregory J.Medical journal of Australia. 2012, Vol 196, Num 10, pp 629-632, issn 0025-729X, 4 p.Article

Can hepatitis C virus infection be eradicated in people who inject drugs?GREBELY, Jason; DORE, Gregory J.Antiviral research. 2014, Vol 104, pp 62-72, issn 0166-3542, 11 p.Article

Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in childrenRERKSUPPAPHOL, Sanguansak; HARDIKAR, Winita; DORE, Gregory J et al.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 12, pp 1357-1362, issn 0815-9319, 6 p.Article

Case definitions for acute hepatitis C virus infection: A systematic reviewHAJARIZADEH, Behzad; GREBELY, Jason; DORE, Gregory J et al.Journal of hepatology. 2012, Vol 57, Num 6, pp 1349-1360, issn 0168-8278, 12 p.Article

HIV and hepatitis C coinfectionMATTHEWS, Gail V; DORE, Gregory J.Journal of gastroenterology and hepatology. 2008, Vol 23, Num 7, pp 1000-1008, issn 0815-9319, 9 p.Article

Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda ForwardGREBELY, Jason; BRUGGMANN, Philip; BACKMUND, Markus et al.Clinical infectious diseases. 2013, Vol 57, issn 1058-4838, 113 p., SUP2Serial Issue

Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovirMATTHEWS, Gail V; COOPER, David A; DORE, Gregory J et al.Antiviral therapy (London). 2007, Vol 12, Num 1, pp 119-122, issn 1359-6535, 4 p.Article

Highly endemic hepatitis B infection in rural VietnamVAN THI-THUY NGUYEN; MCLAWS, Mary-Louise; DORE, Gregory J et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 12, pp 2093-2100, issn 0815-9319, 8 p.Article

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy : a collaborative analysis. CommentaryDORE, Gregory J; COOPER, David A.Lancet (British edition). 2006, Vol 368, Num 9534, issn 0140-6736, 427-428,451-458 [10 p.]Article

Spectrum of AIDS-defining illnesses in australia, 1992 to 1998 : Influence of country/region of birthDORE, Gregory J; YUEMING LI; MCDONALD, Ann et al.Journal of acquired immune deficiency syndromes (1999). 2001, Vol 26, Num 3, pp 283-290, issn 1525-4135Article

Referral for chronic hepatitis C treatment from a drug dependency treatment settingHALLINAN, Richard; BYRNE, Andrew; AGHO, Kingsley et al.Drug and alcohol dependence. 2007, Vol 88, Num 1, pp 49-53, issn 0376-8716, 5 p.Article

Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapyHALLINAN, Richard; BYRNE, Andrew; AMIN, Janaki et al.Journal of gastroenterology and hepatology. 2005, Vol 20, Num 7, pp 1082-1086, issn 0815-9319, 5 p.Article

Enhancing Assessment and Treatment of Hepatitis C in the Custodial SettingPOST, Jeffrey J; ARAIN, Amber; LLOYD, Andrew R et al.Clinical infectious diseases. 2013, Vol 57, issn 1058-4838, S70-S74, SUP2Article

Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter TrialREIMER, Jens; SCHMIDT, Christiane Sybille; SCHULTE, Bernd et al.Clinical infectious diseases. 2013, Vol 57, issn 1058-4838, S97-S104, SUP2Article

Management of Hepatitis C Virus/HIV Coinfection Among People Who Use Drugs in the Era of Direct-Acting Antiviral―Based TherapyTAYLOR, Lynn E; SWAN, Tracy; MATTHEWS, Gail V et al.Clinical infectious diseases. 2013, Vol 57, issn 1058-4838, S118-S124, SUP2Article

No Increase in Hepatitis B Virus (HBV)-Specific CD8⁺ T Cells in Patients with HIV-1―HBV Coinfections following HBV-Active Highly Active Antiretroviral TherapyCRANE, Megan; SIRIVICHAYAKUL, Sunee; DORE, Gregory J et al.Journal of virology. 2010, Vol 84, Num 6, pp 2657-2665, issn 0022-538X, 9 p.Article

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy : a meta-analysisTHEIN, Hla-Hla; QILONG YI; DORE, Gregory J et al.AIDS (London). 2008, Vol 22, Num 15, pp 1979-1991, issn 0269-9370, 13 p.Article

Cancer incidence in people with hepatitis B or C infection : A large community-based linkage studyAMIN, Janaki; DORE, Gregory J; O'CONNELL, Dianne L et al.Journal of hepatology. 2006, Vol 45, Num 2, pp 197-203, issn 0168-8278, 7 p.Article

Treatment for hepatitis C virus infection among current injection drug users in AustraliaMATTHEWS, Gail; KRONBORG, Ian J; DORE, Gregory J et al.Clinical infectious diseases. 2005, Vol 40, pp S325-S329, issn 1058-4838, SUP5Conference Paper

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001LAW, W. Phillip; DORE, Gregory J; DUNCOMBE, Chris J et al.AIDS (London). 2003, Vol 17, Num 15, pp 2191-2199, issn 0269-9370, 9 p.Article

Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, AustraliaNGUYEN, Van T. T; AMIN, Janaki; LAW, Matthew G et al.Journal of gastroenterology and hepatology. 2009, Vol 24, Num 3, pp 436-442, issn 0815-9319, 7 p.Article

Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot studyDOAB, Anna; TOPP, Libby; DAY, Carolyn A et al.Contemporary clinical trials. 2009, Vol 30, Num 5, pp 431-435, issn 1551-7144, 5 p.Article

Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in AustraliaDORE, Gregory J; YUEMING LI; MCDONALD, Ann et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 29, Num 4, pp 388-395, issn 1525-4135Article

Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit AllBRUGGMANN, Philip; LITWIN, Alain H.Clinical infectious diseases. 2013, Vol 57, issn 1058-4838, S56-S61, SUP2Article

Estimation of Stage-Specific Fibrosis Progression Rates in Chronic Hepatitis C Virus Infection : A Meta-Analysis and Meta-RegressionTHEIN, Hla-Hla; QILONG YI; DORE, Gregory J et al.Hepatology (Baltimore, Md.). 2008, Vol 48, Num 2, pp 418-431, issn 0270-9139, 14 p.Article